Crossref
Early initiation or ongoing treatment? Interpreting sodium–glucose cotransporter 2 inhibitor use after acute coronary syndrome
Diabetic Medicine · 16.11.2026
DOI: 10.1111/dme.70533 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetic Medicine, online erschienen am 16.11.2026. Verfasst von Jian Tian. Beteiligte Einrichtung: Outpatient Department, Suizhou Hospital of Traditional Chinese Medicine, Suizhou, Hubei, China. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Outpatient Department, Suizhou Hospital of Traditional Chinese Medicine, Suizhou, Hubei, China.
ORCID-Profile: Jian Tian
Zitieren
APA
Tian, J. (2026). Early initiation or ongoing treatment? Interpreting sodium–glucose cotransporter 2 inhibitor use after acute coronary syndrome. Diabetic Medicine. https://doi.org/10.1111/dme.70533
Vancouver
Tian J. Early initiation or ongoing treatment? Interpreting sodium–glucose cotransporter 2 inhibitor use after acute coronary syndrome. Diabetic Medicine. 2026. doi:10.1111/dme.70533
BibTeX
@article{Tian2026,
author = {Tian, Jian},
title = {Early initiation or ongoing treatment? Interpreting sodium–glucose cotransporter 2 inhibitor use after acute coronary syndrome},
journal = {Diabetic Medicine},
year = {2026},
doi = {10.1111/dme.70533}
}
EUVIMED